The Bitter Lesson of AI-Driven Drug Discovery
Posted4 months agoActive4 months ago
schwabpatrick.comSciencestory
calmnegative
Debate
0/100
Artificial IntelligenceDrug DiscoveryLessons Learned
Key topics
Artificial Intelligence
Drug Discovery
Lessons Learned
The article discusses the challenges and lessons learned from AI-driven drug discovery, highlighting the difficulties in this field.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
11m
Peak period
2
0-1h
Avg / period
2
Key moments
- 01Story posted
Sep 1, 2025 at 11:18 AM EDT
4 months ago
Step 01 - 02First comment
Sep 1, 2025 at 11:29 AM EDT
11m after posting
Step 02 - 03Peak activity
2 comments in 0-1h
Hottest window of the conversation
Step 03 - 04Latest activity
Sep 1, 2025 at 12:16 PM EDT
4 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
ID: 45093390Type: storyLast synced: 11/17/2025, 10:03:39 PM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.
"Unfortunately, working on hypothesis generation remains extremely attractive to AI in drug discovery researchers: (1) day-to-day generating more and more ideas subjectively feels like progress is being made - after all, you’ve created an enormous and ever-growing database of almost-medicines - and (2) science has trained researchers to value invention over doing the hard work to validate ideas, leading to a world in which everyone wants to be the idea-person and comparatively almost no-one wants to be doing the hard and unrewarding work to take these ideas all the way. And so, AI-driven drug discovery researchers still largely pursue hypothesis-generation machines and consequently, as a field, we unfortunately continue to make the same mistakes."